Wilmer Eye Institute, Johns Hopkins University, ...

Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...

Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.

Talley Rostov is a partner at Northwest Eye Surgeons in Seattle, Washington, and serves as a board member and medical liaison for SightLife. She is a consultant for Glaukos.

Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.

In addition to the results, Roche also announced that the US Food and Drug Administration (FDA) has accepted the company’s ...

The US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to ...

Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.

Keith Warren, MD | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology Times, Modern ...

David F. Chang, MD, explained how offering complementary refractive IOLs reduces patient anxiety and indecision.

The course is designed for comprehensive and pediatric ophthalmologists and optometrists, who often see patients with new ...

When people ask how I define a successful premium IOL outcome, they usually expect a number. The honest answer is that a ...